Alfano, Lindsay et al "AVXS-101 Phase 1 Gene Replacement Therapy Clinical Trial in SMA Type 1: Patients Treated Early with the Proposed Therapeutic Dose Were Able to Sit Unassisted at a Younger Age (S29.002)." Neurology 90.15 Supplement (2018): S29.002. Web. 25 Oct. 2021.